Chemicals · Founded 1988 · www.godrejindustries.com · BSE 500164 · NSE GODREJ IND · ISIN INE233A01035
No Notes Added Yet
Business
Godrej Industries Ltd. (GIL) is a diversified Indian conglomerate with core operations in Chemicals, Real Estate (through its subsidiary Godrej Properties Ltd.), and Financial Services. Additionally, GIL acts as a holding company, holding significant stakes in other listed Godrej Group entities, most notably Godrej Consumer Products Ltd. (GCPL) and Godrej Agrovet Ltd. The company generates revenue through the sale of specialty chemicals (oleochemicals and surfactants), development and sale of residential and commercial properties, and providing financial services (primarily through Godrej Finance Ltd.). It also benefits from dividend income and the appreciation of its investments in group companies.
Revenue Mix
Godrej Industries' primary operational segments are:
Chemicals: Manufacturing and selling oleochemicals (e.g., fatty acids, fatty alcohols, glycerine) and surfactant chemicals. These are used in home care, personal care, food, pharmaceuticals, and industrial applications.
Real Estate: This segment is primarily driven by its subsidiary, Godrej Properties Ltd., which develops residential, commercial, and township projects across major Indian cities.
Financial Services: Engaged in lending and other financial activities, primarily focused on specific niches or supporting group activities.
Investments: While not a direct revenue-generating operational segment, GIL holds substantial investments in other listed Godrej Group companies (e.g., Godrej Consumer Products, Godrej Agrovet), which contribute significantly to its overall valuation and receive dividend income.
The revenue mix is dynamic, with Chemicals and Real Estate typically being the largest operational contributors, while the value of the investment portfolio is a major driver of the company's market capitalization.
Industry
Chemicals: Operates in the specialty chemicals and oleochemicals space, which is characterized by a mix of organized and unorganized players. GIL is a leading manufacturer of oleochemicals in India, benefiting from backward integration and a focus on sustainable chemistry. It competes with both domestic and international players.
Real Estate (Godrej Properties): The Indian real estate sector is highly competitive, fragmented, and cyclical. Godrej Properties has positioned itself as a premium national developer known for its brand trust, quality construction, timely delivery, and focus on sustainable development. It competes with other large national and regional developers in key urban markets.
Overall Positioning: GIL leverages the strong "Godrej" brand, which commands significant trust and recall across India, providing a competitive edge in both B2B (chemicals) and B2C (real estate) markets. Its diversified nature provides resilience against downturns in any single sector.
MOAT
Brand Strength: The "Godrej" brand is one of India's most trusted and recognized, built over a century. This strong brand equity instills customer confidence in real estate projects and provides credibility in B2B chemical dealings.
Scale and Backward Integration (Chemicals): A significant player in oleochemicals with integrated manufacturing facilities, potentially offering cost efficiencies and supply chain control.
Diversification & Holding Structure: The diversified portfolio across chemicals, real estate, and financial services, coupled with strategic stakes in other successful group companies, provides inherent stability and multiple avenues for value creation.
Professional Management & Promoter Group: The long-standing, reputed Godrej family as promoters, combined with professional management, ensures stable governance and a long-term strategic vision.
Land Bank & Development Capabilities (Real Estate): Godrej Properties benefits from strategic land parcels and strong capabilities in land acquisition, project design, and execution.
Growth Drivers
Growing Demand for Specialty Chemicals: Increasing demand for sustainable, performance-enhancing chemicals in personal care, home care, and industrial applications, both domestically and for exports. Expansion into new chemical derivatives or chemistries.
Urbanization and Housing Demand: Continued urbanization, rising disposable incomes, and government support for housing (e.g., affordable housing initiatives) are expected to drive growth in the real estate sector for organized players like Godrej Properties.
Focus on New Project Launches (Real Estate): Godrej Properties' strategy of aggressive project acquisitions and new launches in key markets will be a primary growth driver.
Value Unlocking from Investments: Growth and improved performance of underlying businesses like Godrej Consumer Products and Godrej Agrovet directly enhance the value of GIL's investment portfolio.
Financial Services Expansion: Targeted expansion within specific lending segments could contribute to growth.
Risks
Commodity Price Volatility (Chemicals): Fluctuations in raw material prices (e.g., palm oil, crude oil derivatives) can significantly impact the profitability of the Chemicals segment.
Real Estate Cyclicality: The real estate sector is highly sensitive to economic cycles, interest rate changes, regulatory shifts, and consumer sentiment. Delays in project approvals or sales slowdowns pose risks.
Regulatory & Environmental Risks: Changes in environmental norms for chemical manufacturing or stricter real estate regulations (e.g., RERA, construction policies) can impact operations and costs.
Competition: Intense competition across all operating segments from both domestic and international players can put pressure on market share and margins.
Holding Company Discount: GIL often trades at a discount to the sum of the valuations of its underlying assets and investments, and this discount can fluctuate, affecting shareholder returns.
Financial Market Risks: Volatility in capital markets can impact the value of its investment portfolio and the cost of capital for its financial services arm.
Management & Ownership
Godrej Industries is promoted by the Godrej family, a prominent Indian business family with a legacy spanning over a century. The promoter group, led by key members like Nadir Godrej (Chairman & Managing Director) and Pirojsha Godrej (Executive Chairman, Godrej Properties), holds a significant stake in the company, ensuring strong alignment with long-term shareholder interests. The company is professionally managed with a blend of family members and experienced professionals at the helm of its various businesses.
Outlook
Godrej Industries benefits from a diversified business model, a strong legacy brand, and a significant holding in high-growth consumer and real estate businesses. The Chemicals segment is well-positioned to benefit from increasing demand for specialty and sustainable products, while Godrej Properties is capitalizing on urbanization trends and consolidation in the real estate sector. The company's professional management and strong governance provide stability. However, the business is exposed to commodity price volatility in chemicals and the inherent cyclicality of the real estate market. The valuation also frequently carries a holding company discount due to its complex structure. Future performance will largely hinge on its ability to execute effectively in its core operational segments and the sustained growth of its key investments.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3590 | 4567 | 4248 | 4805 | 4825 | 5780 | 4460 | 5032 | 5051 | 7694 |
| Other Income | 254 | 536 | 1011 | 313 | 322 | 620 | 1259 | 1258 | 646 | 581 |
| Total Income | 3844 | 5103 | 5259 | 5118 | 5147 | 6400 | 5719 | 6290 | 5698 | 8274 |
| Total Expenditure | 3311 | 4109 | 3914 | 4230 | 4228 | 5186 | 4063 | 4898 | 4507 | 6527 |
| Operating Profit | 533 | 994 | 1345 | 888 | 919 | 1213 | 1656 | 1391 | 1191 | 1747 |
| Interest | 348 | 369 | 433 | 477 | 505 | 542 | 576 | 584 | 626 | 684 |
| Depreciation | 96 | 100 | 101 | 108 | 111 | 110 | 114 | 121 | 126 | 141 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -64 | -2 |
| Profit Before Tax | 90 | 524 | 812 | 303 | 303 | 560 | 966 | 687 | 375 | 921 |
| Provision for Tax | 51 | 148 | 232 | -60 | 104 | 219 | 333 | 230 | 133 | 285 |
| Profit After Tax | 39 | 377 | 580 | 363 | 199 | 341 | 633 | 457 | 241 | 636 |
| Adjustments | 68 | -689 | -258 | -76 | -11 | -158 | -284 | -214 | -37 | -192 |
| Profit After Adjustments | 106 | -312 | 322 | 288 | 188 | 183 | 349 | 242 | 205 | 444 |
| Adjusted Earnings Per Share | 3.2 | -9.3 | 9.6 | 8.5 | 5.6 | 5.4 | 10.4 | 7.2 | 6.1 | 13.2 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 9230 | 7454 | 8365 | 9076 | 10848 | 11291 | 9334 | 14130 | 16740 | 16601 | 19657 | 22237 |
| Other Income | 126 | 208 | 169 | 1178 | 482 | 572 | 661 | 935 | 1022 | 1496 | 2267 | 3744 |
| Total Income | 9356 | 7661 | 8534 | 10254 | 11330 | 11862 | 9995 | 15065 | 17762 | 18097 | 21924 | 25981 |
| Total Expenditure | 8744 | 7063 | 7724 | 9424 | 10159 | 10480 | 9020 | 13087 | 15230 | 15356 | 17558 | 19995 |
| Operating Profit | 611 | 598 | 810 | 830 | 1171 | 1383 | 975 | 1978 | 2532 | 2741 | 4366 | 5985 |
| Interest | 192 | 343 | 402 | 413 | 508 | 491 | 469 | 623 | 943 | 1352 | 1957 | 2470 |
| Depreciation | 93 | 117 | 148 | 175 | 163 | 234 | 242 | 274 | 305 | 371 | 430 | 502 |
| Exceptional Income / Expenses | 192 | 49 | 23 | 12 | 88 | -10 | 0 | -84 | 0 | 0 | 0 | -66 |
| Profit Before Tax | 519 | 187 | 626 | 597 | 1161 | 909 | 616 | 1282 | 1681 | 964 | 2353 | 2949 |
| Provision for Tax | 137 | 109 | 167 | 113 | 222 | 271 | 226 | 290 | 260 | 369 | 495 | 981 |
| Profit After Tax | 382 | 78 | 459 | 484 | 939 | 638 | 390 | 992 | 1421 | 595 | 1858 | 1967 |
| Adjustments | 20 | 83 | -202 | -147 | -349 | -84 | -55 | -339 | -446 | -535 | -877 | -727 |
| Profit After Adjustments | 402 | 161 | 256 | 338 | 590 | 554 | 335 | 654 | 975 | 60 | 981 | 1240 |
| Adjusted Earnings Per Share | 12 | 4.8 | 7.6 | 10 | 17.5 | 16.5 | 9.9 | 19.4 | 29 | 1.8 | 29.1 | 36.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 18% | 12% | 12% | 8% |
| Operating Profit CAGR | 59% | 30% | 26% | 22% |
| PAT CAGR | 212% | 23% | 24% | 17% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -12% | 30% | 14% | 11% |
| ROE Average | 21% | 16% | 13% | 14% |
| ROCE Average | 10% | 9% | 9% | 10% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 3227 | 3002 | 3196 | 3334 | 4346 | 5788 | 7553 | 7127 | 7984 | 8001 | 10152 |
| Minority's Interest | 1149 | 1281 | 1475 | 1357 | 2212 | 3562 | 5817 | 5954 | 6317 | 7118 | 11196 |
| Borrowings | 1728 | 1574 | 1508 | 952 | 1196 | 613 | 3111 | 5453 | 7084 | 11593 | 19101 |
| Other Non-Current Liabilities | 584 | 70 | 8 | -490 | -322 | -171 | 80 | 12 | -14 | 12 | 191 |
| Total Current Liabilities | 7316 | 8206 | 8745 | 11068 | 10037 | 10157 | 12043 | 15070 | 22135 | 34386 | 47000 |
| Total Liabilities | 14003 | 14133 | 14931 | 16222 | 17622 | 19950 | 28604 | 33616 | 43506 | 61110 | 87639 |
| Fixed Assets | 1837 | 2837 | 3160 | 3166 | 3682 | 3879 | 4025 | 4646 | 4950 | 6050 | 6374 |
| Other Non-Current Assets | 3595 | 3226 | 3386 | 4337 | 5210 | 5498 | 6962 | 8504 | 12456 | 15676 | 21626 |
| Total Current Assets | 8571 | 8070 | 8386 | 8719 | 8573 | 10573 | 17617 | 20466 | 26100 | 39385 | 59633 |
| Total Assets | 14003 | 14133 | 14931 | 16222 | 17622 | 19950 | 28604 | 33616 | 43506 | 61110 | 87639 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 287 | 57 | 118 | -75 | -361 | 574 | 442 | 394 | 600 | 1577 | 1865 |
| Cash Flow from Operating Activities | -1050 | 199 | 569 | 1689 | 1240 | 392 | -672 | -1756 | -4409 | -4284 | -5151 |
| Cash Flow from Investing Activities | -458 | -188 | -234 | -1016 | -1373 | -1874 | -5152 | 43 | 1775 | -2752 | -4597 |
| Cash Flow from Financing Activities | 1409 | 2 | -528 | -959 | 1056 | 1349 | 5772 | 1916 | 3535 | 7219 | 10689 |
| Net Cash Inflow / Outflow | -98 | 13 | -193 | -286 | 923 | -133 | -52 | 203 | 901 | 183 | 941 |
| Closing Cash & Cash Equivalent | 188 | 74 | -76 | -361 | 574 | 442 | 394 | 600 | 1577 | 1865 | 2841 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 11.98 | 4.78 | 7.63 | 10.05 | 17.52 | 16.46 | 9.94 | 19.42 | 28.96 | 1.78 | 29.14 |
| CEPS(Rs) | 14.16 | 5.81 | 18.06 | 19.61 | 32.75 | 25.9 | 18.78 | 37.61 | 51.25 | 28.69 | 67.95 |
| DPS(Rs) | 1.75 | 1.75 | 1.75 | 1.75 | 1.15 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 93.41 | 87.02 | 94.87 | 98.92 | 128.9 | 171.73 | 224.16 | 211.47 | 236.9 | 237.28 | 301.01 |
| Core EBITDA Margin(%) | 5.21 | 5.17 | 7.56 | -3.81 | 6.2 | 7.04 | 3.29 | 7.25 | 8.85 | 7.31 | 10.4 |
| EBIT Margin(%) | 7.62 | 7.02 | 12.12 | 11.07 | 15 | 12.15 | 11.38 | 13.23 | 15.38 | 13.61 | 21.35 |
| Pre Tax Margin(%) | 5.56 | 2.47 | 7.38 | 6.54 | 10.44 | 7.89 | 6.46 | 8.91 | 9.85 | 5.67 | 11.66 |
| PAT Margin (%) | 4.1 | 1.03 | 5.41 | 5.31 | 8.44 | 5.54 | 4.09 | 6.89 | 8.33 | 3.5 | 9.21 |
| Cash Profit Margin (%) | 5.1 | 2.58 | 7.16 | 7.23 | 9.91 | 7.57 | 6.63 | 8.79 | 10.11 | 5.68 | 11.34 |
| ROA(%) | 3.03 | 0.55 | 3.16 | 3.11 | 5.55 | 3.4 | 1.61 | 3.19 | 3.68 | 1.14 | 2.5 |
| ROE(%) | 12.91 | 2.57 | 15.01 | 14.87 | 24.5 | 12.61 | 5.85 | 13.54 | 18.83 | 7.46 | 20.5 |
| ROCE(%) | 8.87 | 5.51 | 9.85 | 9.62 | 15.37 | 11.44 | 7.11 | 9.77 | 10.72 | 7.21 | 10.16 |
| Receivable days | 23.04 | 36.01 | 37.9 | 38.15 | 35.47 | 42.96 | 58.88 | 40.55 | 33.98 | 29.76 | 26.32 |
| Inventory Days | 190.06 | 247.41 | 212.99 | 196.8 | 135.03 | 104.5 | 179.53 | 176.27 | 232.11 | 411.98 | 534.99 |
| Payable days | 58.15 | 104.93 | 81.61 | 57.12 | 46.86 | 55.23 | 198.19 | 127.52 | 307.91 | -2023.13 | -3248.06 |
| PER(x) | 28.83 | 74.08 | 66.12 | 54.54 | 30.59 | 17.23 | 54.57 | 23.84 | 13.95 | 438.16 | 38.93 |
| Price/Book(x) | 3.7 | 4.07 | 5.32 | 5.54 | 4.16 | 1.65 | 2.42 | 2.19 | 1.71 | 3.29 | 3.77 |
| Dividend Yield(%) | 0.51 | 0.49 | 0.35 | 0.32 | 0.21 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.87 | 2.53 | 2.9 | 2.74 | 2.23 | 1.4 | 2.93 | 1.99 | 1.8 | 3.11 | 3.52 |
| EV/Core EBITDA(x) | 28.21 | 31.49 | 29.98 | 29.92 | 20.67 | 11.42 | 28.07 | 14.23 | 11.88 | 18.82 | 15.87 |
| Net Sales Growth(%) | 16.57 | -19.25 | 12.23 | 8.49 | 19.53 | 4.08 | -17.97 | 51.39 | 18.47 | -0.83 | 18.41 |
| EBIT Growth(%) | 21.33 | -25.46 | 32.7 | -1.75 | 65.21 | -16.09 | -31.18 | 75.64 | 37.67 | -11.68 | 86.03 |
| PAT Growth(%) | 29.34 | -79.62 | 42.05 | 5.57 | 93.81 | -32.05 | -51.97 | 154.61 | 43.15 | -58.11 | 212.23 |
| EPS Growth(%) | 21.69 | -60.07 | 59.47 | 31.65 | 74.45 | -6.09 | -39.59 | 95.36 | 49.11 | -93.85 | 1535.98 |
| Debt/Equity(x) | 1.88 | 2.44 | 2.37 | 2.08 | 1.64 | 1.25 | 1.32 | 2.02 | 2.44 | 3.61 | 3.73 |
| Current Ratio(x) | 1.17 | 0.98 | 0.96 | 0.79 | 0.85 | 1.04 | 1.46 | 1.36 | 1.18 | 1.15 | 1.27 |
| Quick Ratio(x) | 0.44 | 0.39 | 0.38 | 0.35 | 0.51 | 0.73 | 0.95 | 0.85 | 0.55 | 0.43 | 0.53 |
| Interest Cover(x) | 3.71 | 1.54 | 2.56 | 2.44 | 3.29 | 2.85 | 2.31 | 3.06 | 2.78 | 1.71 | 2.2 |
| Total Debt/Mcap(x) | 0.51 | 0.6 | 0.45 | 0.38 | 0.39 | 0.76 | 0.55 | 0.92 | 1.43 | 1.1 | 0.99 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 67.16 | 67.16 | 67.16 | 67.69 | 65.73 | 69.65 | 70.97 | 71.31 | 74.64 | 74.64 |
| FII | 10.17 | 7.93 | 8.02 | 8.38 | 8.24 | 6.97 | 5.66 | 5.12 | 4.86 | 4.47 |
| DII | 2.91 | 4.86 | 5.02 | 4.76 | 4.42 | 2.5 | 2.54 | 2.77 | 3.29 | 3.48 |
| Public | 19.76 | 20.05 | 19.8 | 19.17 | 21.61 | 20.88 | 20.83 | 20.81 | 17.22 | 17.41 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 22.61 | 22.61 | 22.61 | 22.79 | 22.14 | 23.45 | 23.9 | 24.02 | 25.14 | 25.14 |
| FII | 3.43 | 2.67 | 2.7 | 2.82 | 2.78 | 2.35 | 1.91 | 1.72 | 1.64 | 1.51 |
| DII | 0.98 | 1.64 | 1.69 | 1.6 | 1.49 | 0.84 | 0.85 | 0.93 | 1.11 | 1.17 |
| Public | 6.65 | 6.75 | 6.67 | 6.46 | 7.28 | 7.03 | 7.01 | 7.01 | 5.8 | 5.87 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 33.67 | 33.67 | 33.67 | 33.68 | 33.68 | 33.68 | 33.68 | 33.68 | 33.68 | 33.68 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +18% | +12% | +12% | +8% |
| Operating Profit CAGR | +59% | +30% | +26% | +22% |
| PAT CAGR | +212% | +23% | +24% | +17% |
| Share Price CAGR | -12% | +30% | +14% | +11% |
| ROE Average | +21% | +16% | +13% | +14% |
| ROCE Average | +10% | +9% | +9% | +10% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 67.16 | 67.16 | 67.16 | 67.69 | 65.73 | 69.65 | 70.97 | 71.31 | 74.64 | 74.64 |
| FII | 10.17 | 7.93 | 8.02 | 8.38 | 8.24 | 6.97 | 5.66 | 5.12 | 4.86 | 4.47 |
| DII | 2.91 | 4.86 | 5.02 | 4.76 | 4.42 | 2.5 | 2.54 | 2.77 | 3.29 | 3.48 |
| Public | 32.84 | 32.84 | 32.84 | 32.31 | 34.27 | 30.35 | 29.03 | 28.69 | 25.36 | 25.36 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 22.61 | 22.61 | 22.61 | 22.79 | 22.14 | 23.45 | 23.9 | 24.02 | 25.14 | 25.14 |
| FII | 3.43 | 2.67 | 2.7 | 2.82 | 2.78 | 2.35 | 1.91 | 1.72 | 1.64 | 1.51 |
| DII | 0.98 | 1.64 | 1.69 | 1.6 | 1.49 | 0.84 | 0.85 | 0.93 | 1.11 | 1.17 |
| Public | 11.06 | 11.06 | 11.06 | 10.88 | 11.54 | 10.22 | 9.78 | 9.66 | 8.54 | 8.54 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 33.67 | 33.67 | 33.67 | 33.68 | 33.68 | 33.68 | 33.68 | 33.68 | 33.68 | 33.68 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.